OrthoCyte Corp. is a wholly- owned subsidiary of BioTime, Inc. developing cellular therapeutics for orthopedic repair diseases
and injuries. Our lead project is the development of human embryonic progenitor cell (hEPC) lines for cartilage repair. We have
identified several ACTCellerate cell lines that display chondrogenic (cartilage-producing) potential and these are being tested in
advanced in vivo systems for effective cartilage repair....
